{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T22:18:26Z","timestamp":1794435506219,"version":"4.9.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,24]]},"DOI":"10.7759\/cureus.11686","type":"journal-article","created":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T01:36:23Z","timestamp":1606268183000},"source":"Crossref","is-referenced-by-count":313,"title":["Epidemiology of Glaucoma: The Past, Present, and Predictions for the Future"],"prefix":"10.7759","author":[{"given":"Karen","family":"Allison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepkumar","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omobolanle","family":"Alabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/6509809","article-title":"Medical Management of Glaucoma in the 21st Century from a Canadian Perspective","volume":"2016","author":"Harasymowycz P","year":"2016","unstructured":"Harasymowycz P, Birt C, Gooi P, et al.. Medical Management of Glaucoma in the 21st Century from a Canadian Perspective. J Ophthalmol. 2016, 2016:6509809. 10.1155\/2016\/6509809","journal-title":"J Ophthalmol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.67","article-title":"Primary open-angle glaucoma","volume":"2","author":"Weinreb RN","year":"2016","unstructured":"Weinreb RN, Leung CK, Crowston JG, Medeiros FA, Friedman DS, Wiggs JL, Martin KR. Primary open-angle glaucoma. Nat Rev Dis Primers. 2016, 2:16067. 10.1038\/nrdp.2016.67","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0137913","article-title":"The cost-effectiveness analysis of teleglaucoma screening device","volume":"10","author":"Thomas S","year":"2015","unstructured":"Thomas S, Hodge W, Malvankar-Mehta M. The cost-effectiveness analysis of teleglaucoma screening device. PLoS One. 2015, 10:e0137913. 10.1371\/journal.pone.0137913","journal-title":"PLoS One"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp16X685165","article-title":"Glaucoma: the patient's perspective","volume":"66","author":"Imrie C","year":"2016","unstructured":"Imrie C, Tatham AJ. Glaucoma: the patient's perspective. Br J Gen Pract. 2016, 66:e371-373. 10.3399\/bjgp16X685165","journal-title":"Br J Gen Pract"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.joco.2018.05.003","article-title":"Prevalence and risk factors of glaucoma in an adult population from Shahroud, Iran","volume":"31","author":"Hashemi H","year":"2018","unstructured":"Hashemi H, Mohammadi M, Zandvakil N, Khabazkhoob M, Emamian MH, Shariati M, Fotouhi A. Prevalence and risk factors of glaucoma in an adult population from Shahroud, Iran. J Curr Ophthalmol. 2018, 31:366-372. 10.1016\/j.joco.2018.05.003","journal-title":"J Curr Ophthalmol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.optom.2016.02.003","article-title":"Glaucoma history and risk factors","volume":"10","author":"McMonnies CW","year":"2017","unstructured":"McMonnies CW. Glaucoma history and risk factors. J Optom. 2017, 10:71-78. 10.1016\/j.optom.2016.02.003","journal-title":"J Optom"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddx184","article-title":"Genetics of glaucoma","volume":"26","author":"Wiggs JL","year":"2017","unstructured":"Wiggs JL, Pasquale LR. Genetics of glaucoma. Hum Mol Genet. 2017, 26:R21-R27. 10.1093\/hmg\/ddx184","journal-title":"Hum Mol Genet"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307223","article-title":"Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis","volume":"100","author":"Kapetanakis VV","year":"2016","unstructured":"Kapetanakis VV, Chan MP, Foster PJ, Cook DG, Owen CG, Rudnicka AR. Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis. Br J Ophthalmol. 2016, 100:86-93. 10.1136\/bjophthalmol-2015-307223","journal-title":"Br J Ophthalmol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-019-6935-6","article-title":"Prevalence, incidence, and risk factors of primary open-angle glaucoma - a cohort study based on longitudinal data from a German public health insurance","volume":"19","author":"Kreft D","year":"2019","unstructured":"Kreft D, Doblhammer G, Guthoff RF, Frech S. Prevalence, incidence, and risk factors of primary open-angle glaucoma - a cohort study based on longitudinal data from a German public health insurance. BMC Public Health. 2019, 19:851. 10.1186\/s12889-019-6935-6","journal-title":"BMC Public Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham YC","year":"2014","unstructured":"Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014, 121:2081-2090. 10.1016\/j.ophtha.2014.05.013","journal-title":"Ophthalmology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-015-0160-6","article-title":"A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey","volume":"15","author":"Kyari F","year":"2015","unstructured":"Kyari F, Entekume G, Rabiu M, et al.. A Population-based survey of the prevalence and types of glaucoma in Nigeria: results from the Nigeria National Blindness and Visual Impairment Survey. BMC Ophthalmol. 2015, 15:176. 10.1186\/s12886-015-0160-6","journal-title":"BMC Ophthalmol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2019.10.028","article-title":"Effects of an aging population and racial demographics on eye disease prevalence: projections for Georgia through 2050","volume":"210","author":"Kelly E","year":"2020","unstructured":"Kelly E, Wen Q, Haddad D, O'Banion J. Effects of an aging population and racial demographics on eye disease prevalence: projections for Georgia through 2050. Am J Ophthalmol. 2020, 210:35-40. 10.1016\/j.ajo.2019.10.028","journal-title":"Am J Ophthalmol"},{"key":"ref13","unstructured":"Centers for Disease Control and Prevention. Vision and Eye Health Surveillance System (VEHSS0). (2018). Accessed: November 23, 2020: https:\/\/www.cdc.gov\/visionhealth\/vehss\/data\/studies\/glaucoma.html."},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4257151","article-title":"Glaucoma quality of life","volume":"2017","author":"Fea AM","year":"2017","unstructured":"Fea AM, Hengerer F, Lavia C, Au L. Glaucoma quality of life. J Ophthalmol. 2017, 2017:4257151. 10.1155\/2017\/4257151","journal-title":"J Ophthalmol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-016-0333-6","article-title":"Quality of life in glaucoma: a review of the literature","volume":"33","author":"Quaranta L","year":"2016","unstructured":"Quaranta L, Riva I, Gerardi C, Oddone F, Floriani I, Konstas AG. Quality of life in glaucoma: a review of the literature. Adv Ther. 2016, 33:959-981. 10.1007\/s12325-016-0333-6","journal-title":"Adv Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2015.5479","article-title":"Self-reported function, health resource use, and total health care costs among Medicare beneficiaries with glaucoma","volume":"134","author":"Prager AJ","year":"2016","unstructured":"Prager AJ, Liebmann JM, Cioffi GA, Blumberg DM. Self-reported function, health resource use, and total health care costs among Medicare beneficiaries with glaucoma. JAMA Ophthalmol. 2016, 134:357-365. 10.1001\/jamaophthalmol.2015.5479","journal-title":"JAMA Ophthalmol"},{"key":"ref17","article-title":"Socioeconomic influence of glaucoma on patients","volume":"9","author":"Merepa SS","year":"2018","unstructured":"Merepa SS, Kumah DB, Akowuah K, et al.. Socioeconomic influence of glaucoma on patients. EC Ophthalmology. 2018, 9:3-9.","journal-title":"EC Ophthalmology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/nu11051002","article-title":"Dietary antioxidants, macular pigment, and glaucomatous neurodegeneration: a review of the evidence","volume":"11","author":"Lawler T","year":"2019","unstructured":"Lawler T, Liu Y, Christensen K, Vajaranant TS, Mares J. Dietary antioxidants, macular pigment, and glaucomatous neurodegeneration: a review of the evidence. Nutrients. 2019, 11:1002. 10.3390\/nu11051002","journal-title":"Nutrients"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S236030","article-title":"Current knowledge and attitudes concerning cost-effectiveness in glaucoma pharmacotherapy: a glaucoma specialists focus group study","volume":"14","author":"Feldman RM","year":"2020","unstructured":"Feldman RM, Cioffi GA, Liebmann JM, Weinreb RN. Current knowledge and attitudes concerning cost-effectiveness in glaucoma pharmacotherapy: a glaucoma specialists focus group study. Clin Ophthalmol. 2020, 14:729-739. 10.2147\/OPTH.S236030","journal-title":"Clin Ophthalmol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2019.1646262","article-title":"The cost burden of falls in people with glaucoma in National Health Service Hospital Trusts in the UK","volume":"23","author":"McGinley P","year":"2020","unstructured":"McGinley P, Ansari E, Sandhu H, Dixon T. The cost burden of falls in people with glaucoma in National Health Service Hospital Trusts in the UK. J Med Econ. 2020, 23:106-112. 10.1080\/13696998.2019.1646262","journal-title":"J Med Econ"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/547960","article-title":"Comparison of United States and Canadian glaucoma medication costs and price change from 2006 to 2013","volume":"2015","author":"Schlenker MB","year":"2015","unstructured":"Schlenker MB, Trope GE, Buys YM. Comparison of United States and Canadian glaucoma medication costs and price change from 2006 to 2013. J Ophthalmol. 2015, 2015:547960. 10.1155\/2015\/547960","journal-title":"J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14044","article-title":"Epidemiological variations and trends in health burden of glaucoma worldwide","volume":"97","author":"Wang W","year":"2019","unstructured":"Wang W, He M, Li Z, Huang W. Epidemiological variations and trends in health burden of glaucoma worldwide. Acta Ophthalmol. 2019, 97:e349-e355. 10.1111\/aos.14044","journal-title":"Acta Ophthalmol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2014.3333","article-title":"Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan","volume":"132","author":"Hwang DK","year":"2014","unstructured":"Hwang DK, Liu CJ, Pu CY, Chou YJ, Chou P. Persistence of topical glaucoma medication: a nationwide population-based cohort study in Taiwan. JAMA Ophthalmol. 2014, 132:1446-1452. 10.1001\/jamaophthalmol.2014.3333","journal-title":"JAMA Ophthalmol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0113779","article-title":"The effectiveness of teleglaucoma versus in-patient examination for glaucoma screening: a systematic review and meta-analysis","volume":"9","author":"Thomas SM","year":"2014","unstructured":"Thomas SM, Jeyaraman MM, Hodge WG, Hutnik C, Costella J, Malvankar-Mehta MS. The effectiveness of teleglaucoma versus in-patient examination for glaucoma screening: a systematic review and meta-analysis. PloS One. 2014, 9:e113779. 10.1371\/journal.pone.0113779","journal-title":"PloS One"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcjo.2013.11.005","article-title":"Northern Alberta remote teleglaucoma program: clinical outcomes and patient disposition","volume":"49","author":"Verma S","year":"2014","unstructured":"Verma S, Arora S, Kassam F, Edwards MC, Damji KF. Northern Alberta remote teleglaucoma program: clinical outcomes and patient disposition. Can J Ophthalmol. 2014, 49:135-140. 10.1016\/j.jcjo.2013.11.005","journal-title":"Can J Ophthalmol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s40142-017-0131-8","article-title":"Primary open-angle glaucoma genetics in African Americans","volume":"5","author":"Restrepo NA","year":"2017","unstructured":"Restrepo NA, Cooke Bailey JN. Primary open-angle glaucoma genetics in African Americans. Curr Genet Med Rep. 2017, 5:167-174. 10.1007\/s40142-017-0131-8","journal-title":"Curr Genet Med Rep"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/42672-epidemiology-of-glaucoma-the-past-present-and-predictions-for-the-future","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:22:44Z","timestamp":1707506564000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/42672-epidemiology-of-glaucoma-the-past-present-and-predictions-for-the-future"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,24]]},"references-count":26,"URL":"https:\/\/doi.org\/10.7759\/cureus.11686","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,24]]}}}